MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences ROE Ratio 2011-2026 | ANIX
Annual ROE Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.07 | -62.78 | -40.31 | -46.8 | -36.55 | -122.12 | -242.02 | -270.01 | -63.22 | -508.01 | -27.29 | -239.58 | 303.56 | 356.16 | -697.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 356.16 | -697.34 | -117.89 |
Quarterly ROE Ratio Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61.59 | -50.02 | -65.86 | -68.09 | -64.63 | -42.97 | -53.18 | -47.56 | -42.49 | -27.67 | -62.51 | -61.18 | -63.63 | -71.24 | -61.63 | -64.84 | -60.32 | -91.7 | -155.44 | -172.59 | -195.95 | -238.98 | -332.61 | -344.25 | -363.3 | -301.22 | -281.49 | -341.39 | -317.57 | -194.78 | -72.6 | 5.53 | 32.92 | -105.67 | -466.89 | -556.02 | -686.85 | -597.05 | -196.85 | -116.78 | -32.24 | -13.92 | -173.15 | -131.19 | -167.98 | -73.5 | 302.86 | 370.37 | 525.99 | 247.68 | 188.07 | 163.01 | 161.88 | 18.13 | -401.51 | -621.82 | -553.09 | -263.83 | -167.62 | -121.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 525.99 | -686.85 | -130.07 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 14.0 | 2.56 % | $ 99.4 M |  Israel |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
12.35 | $ 8.91 | 0.51 % | $ 594 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.85 | 0.08 % | $ 718 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
30.46 | $ 67.92 | 2.38 % | $ 26.5 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 157.08 | 3.45 % | $ 7.79 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.51 | 1.07 % | $ 933 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.81 | -0.04 % | $ 19.6 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 87.36 | 0.2 % | $ 11 B | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.45 | 3.34 % | $ 467 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 17.14 | -0.87 % | $ 2.22 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 100.87 | 3.33 % | $ 8.32 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
20.91 | $ 170.64 | 3.54 % | $ 29.3 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 196.09 | 2.46 % | $ 140 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 120.51 | 1.03 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 199.89 | 0.48 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
22.45 | $ 114.44 | 2.33 % | $ 34.8 B | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.11 | -0.45 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 8.74 | 3.8 % | $ 248 M | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.31 | 2.2 % | $ 2.02 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 78.85 | 0.45 % | $ 5.32 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.39 | 1.84 % | $ 417 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 461.07 | 1.64 % | $ 13.3 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 224.83 | 2.14 % | $ 25.2 B |  Schweiz |
 |
Celcuity
CELC
|
-96.68 | $ 113.19 | -1.49 % | $ 4.47 B | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.02 | 3.56 % | $ 403 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.4 | 2.0 % | $ 1.08 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-77.62 | $ 201.85 | 2.11 % | $ 19.9 B | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.2 | 0.84 % | $ 833 M | USA |